INTERNATIONAL PATENT: CHROMA MEDICINE, INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF TGFBR2 EXPRESSION"

GENEVA, March 10 -- CHROMA MEDICINE, INC. (201 Brookline AvenueSuite 1101Boston, MA 02215) filed a patent application (PCT/US2024/044501) for "COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF TGFBR2 EXPRESSION" on Aug 29, 2024. With publication no. WO/2025/049792, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COLLINS, McKensie Alexis (c/o Chroma Medicine, Inc.201 Brookline Avenue, Suite 1101Boston, MA 02215), FRIEDLAND, Ari (5 Rindge TerraceCambridge, MA 02140), JAFEE, Aron Brandon (c/o Chroma Medicine, Inc.201 Bro...